Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basile

Showing results (311-320 of 7,142) with videos related to

Pageof 715
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
Analysis of Recent Papers in HypertensionJan Basile, Walter A. Brzezinski
FEMS Microbiology Ecology|May 27, 2010
Maintenance of phenol hydroxylase genotypes at high diversity in bioreactors exposed to step increases in phenol loadingLaura A Basile, Leonardo Erijman
Journal of Clinical Hypertension (Greenwich, Conn.)|June 27, 2003
The diagnosis and management of renovascular disease: a primary care perspective. Part I. Making the diagnosisMichael J Bloch, Jan Basile
Journal of Pharmacological Methods|April 1, 1987
Preservation of "peripheral" benzodiazepine receptors: differential effects of freezing on [3H]Ro 5-4864 and [3H]PK 11195 bindingA S Basile, P Skolnick
Minerva Medica|October 7, 2004
Clinical insights into the diagnosis and management of renovascular disease. An evidence-based reviewM J Bloch, J Basile
Applied Microbiology and Biotechnology|January 19, 2008
Quantitative assessment of phenol hydroxylase diversity in bioreactors using a functional gene analysisLaura A Basile, Leonardo Erijman
Journal of Clinical Hypertension (Greenwich, Conn.)|March 7, 2008
Cholesterol ester transfer protein inhibition with torcetrapib leads to an increase in cardiovascular events: an effect that is unlikely to be the result of increases in blood pressure aloneMichael J Bloch, Jan Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|March 29, 2008
Chronotherapy in patients with chronic kidney disease to reduce nighttime blood pressure--not ready for prime timeMichael J Bloch, Jan Basile
Journal of Human Hypertension|January 7, 2006
The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapyJ N Basile, S Chrysant
Journal of Clinical Hypertension (Greenwich, Conn.)|February 1, 2008
Prompt, aggressive BP lowering in high-risk patientsKenneth A Jamerson, Jan Basile
Pageof 715

Showing results (311-320 of 7,142) with videos related to

Sort By:
Pageof 715
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
Analysis of Recent Papers in HypertensionJan Basile, Walter A. Brzezinski
FEMS Microbiology Ecology|May 27, 2010
Maintenance of phenol hydroxylase genotypes at high diversity in bioreactors exposed to step increases in phenol loadingLaura A Basile, Leonardo Erijman
Journal of Clinical Hypertension (Greenwich, Conn.)|June 27, 2003
The diagnosis and management of renovascular disease: a primary care perspective. Part I. Making the diagnosisMichael J Bloch, Jan Basile
Journal of Pharmacological Methods|April 1, 1987
Preservation of "peripheral" benzodiazepine receptors: differential effects of freezing on [3H]Ro 5-4864 and [3H]PK 11195 bindingA S Basile, P Skolnick
Minerva Medica|October 7, 2004
Clinical insights into the diagnosis and management of renovascular disease. An evidence-based reviewM J Bloch, J Basile
Applied Microbiology and Biotechnology|January 19, 2008
Quantitative assessment of phenol hydroxylase diversity in bioreactors using a functional gene analysisLaura A Basile, Leonardo Erijman
Journal of Clinical Hypertension (Greenwich, Conn.)|March 7, 2008
Cholesterol ester transfer protein inhibition with torcetrapib leads to an increase in cardiovascular events: an effect that is unlikely to be the result of increases in blood pressure aloneMichael J Bloch, Jan Basile
Journal of Clinical Hypertension (Greenwich, Conn.)|March 29, 2008
Chronotherapy in patients with chronic kidney disease to reduce nighttime blood pressure--not ready for prime timeMichael J Bloch, Jan Basile
Journal of Human Hypertension|January 7, 2006
The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapyJ N Basile, S Chrysant
Journal of Clinical Hypertension (Greenwich, Conn.)|February 1, 2008
Prompt, aggressive BP lowering in high-risk patientsKenneth A Jamerson, Jan Basile
Pageof 715